Gordon Dougan is a microbiologist and genome scientist who explores the influence of genetics and environment on the interaction between microbes and the hosts they infect. He has focused particularly on Salmonella Typhi, which causes typhoid, and other enteric bacteria — those that invade the gut. He is also an expert in vaccinology and has worked extensively in industry in this area.
Underpinning Gordon’s research is his dedication to delivering improved vaccines for the developing world, especially those designed to boost the immune response of the mucous membranes that line the gastrointestinal tract. His peers recognised his leadership in research and clinical trials when, in 2014, they named him amongst the top ten most influential people in the vaccine field.
Having spent his early career in the pharmaceutical industry, Gordon now heads the Microbial Pathogenesis group at the Wellcome Trust Sanger Institute. He remains an adviser to industry and to global agencies such as the World Health Organization (WHO), and has spun out a number of companies.
Professional position
- GSK Professor, Department of Medicine, University of Cambridge
- Chair, University of Cambridge
Subject groups
-
Molecules of Life
Molecular microbiology
-
Other
Other interests
